These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21137083)

  • 1. Identification of diabetic nephropathy-selective proteins in human plasma by multi-lectin affinity chromatography and LC-MS/MS.
    Ahn JM; Kim BG; Yu MH; Lee IK; Cho JY
    Proteomics Clin Appl; 2010 Jul; 4(6-7):644-53. PubMed ID: 21137083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset.
    Metz TO; Qian WJ; Jacobs JM; Gritsenko MA; Moore RJ; Polpitiya AD; Monroe ME; Camp DG; Mueller PW; Smith RD
    J Proteome Res; 2008 Feb; 7(2):698-707. PubMed ID: 18092746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential urinary glycoproteome analysis of type 2 diabetic nephropathy using 2D-LC-MS/MS and iTRAQ quantification.
    Guo Z; Liu X; Li M; Shao C; Tao J; Sun W; Li M
    J Transl Med; 2015 Nov; 13():371. PubMed ID: 26608305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome analysis of serum from type 2 diabetics with nephropathy.
    Kim HJ; Cho EH; Yoo JH; Kim PK; Shin JS; Kim MR; Kim CW
    J Proteome Res; 2007 Feb; 6(2):735-43. PubMed ID: 17269729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Succinic acid enhanced quantitative determination of blood modified nucleosides in the development of diabetic nephropathy based on hydrophilic interaction liquid chromatography mass spectrometry.
    Guo M; Liu D; Sha Q; Geng H; Liang J; Tang D
    J Pharm Biomed Anal; 2019 Feb; 164():309-316. PubMed ID: 30412804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
    Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
    Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
    Zhu C; Liang QL; Hu P; Wang YM; Luo GA
    Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
    Wang S; Wang Y; Zheng R; Zhao Z; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
    Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
    J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in plasma concentrations of vitronectin in patients with diabetic nephropathy.
    Morioka S; Makino H; Shikata K; Ota Z
    Acta Med Okayama; 1994 Jun; 48(3):137-42. PubMed ID: 7524268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary exosomes and diabetic nephropathy: a proteomic approach.
    Raimondo F; Corbetta S; Morosi L; Chinello C; Gianazza E; Castoldi G; Di Gioia C; Bombardi C; Stella A; Battaglia C; Bianchi C; Magni F; Pitto M
    Mol Biosyst; 2013 Jun; 9(6):1139-46. PubMed ID: 23344851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum ApoA4 levels predicted the progression of renal impairment in T2DM.
    Cheng CW; Chang CC; Chen HW; Lin CY; Chen JS
    Eur J Clin Invest; 2018 Jun; 48(6):e12937. PubMed ID: 29675916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic identification of urinary biomarkers of diabetic nephropathy.
    Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
    Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary Glycopatterns as Potential Non-Invasive Biomarkers for Diagnosing and Reflecting Severity and Prognosis of Diabetic Nephropathy.
    Han Q; Wang X; Ding X; Hao J; Li Q; Wang J; Yu H; Tang Z; Yang F; Cai G; Zhang D; Zhu H
    Front Endocrinol (Lausanne); 2022; 13():790586. PubMed ID: 35432212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Blood Plasma Glycoproteome Coverage by Coupling Ultracentrifugation Fractionation to Electrostatic Repulsion-Hydrophilic Interaction Chromatography Enrichment.
    Adav SS; Hwa HH; de Kleijn D; Sze SK
    J Proteome Res; 2015 Jul; 14(7):2828-38. PubMed ID: 26044363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
    Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
    Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SH3YL1 protein as a novel biomarker for diabetic nephropathy in type 2 diabetes mellitus.
    Choi GS; Min HS; Cha JJ; Lee JE; Ghee JY; Yoo JA; Kim KT; Kang YS; Han SY; Bae YS; Lee SR; Yoo JY; Moon SH; Lee SJ; Cha DR
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):498-505. PubMed ID: 33223406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitivity profiling of glycoproteins from human blood serum through multiple-lectin affinity chromatography and liquid chromatography/tandem mass spectrometry.
    Madera M; Mechref Y; Klouckova I; Novotny MV
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jan; 845(1):121-37. PubMed ID: 16987717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic identification of vanin-1 as a marker of kidney damage in a rat model of type 1 diabetic nephropathy.
    Fugmann T; Borgia B; Révész C; Godó M; Forsblom C; Hamar P; Holthöfer H; Neri D; Roesli C
    Kidney Int; 2011 Aug; 80(3):272-81. PubMed ID: 21544065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.